The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus

被引:51
作者
Sumethkul, Kittiwan [1 ]
Boonyaratavej, Smonporn [2 ]
Kitumnuaypong, Tasanee [1 ]
Angthararuk, Sungchai [1 ]
Cheewasat, Patcharin [1 ]
Manadee, Naruimon [1 ]
Sumethkul, Vasant [3 ]
机构
[1] Rajavithi Hosp, Dept Med, Rheumatol Unit, Bangkok 10400, Thailand
[2] Chulalongkorn Univ, Fac Med, Div Cardiol, Bangkok 10330, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Nephrol, Bangkok 10400, Thailand
关键词
25-Hydroxyvitamin D; Vitamin D deficiency; Serum 25(OH) D; Systemic lupus erythematosus; Lupus nephritis; Proteinuria; RANDOMIZED CONTROLLED-TRIAL; D-RECEPTOR ACTIVATION; DISEASE-ACTIVITY; NATIONAL-HEALTH; ASSOCIATION; PARICALCITOL; ALBUMINURIA; PROTEINURIA; REDUCTION; SLE;
D O I
10.1007/s00296-012-2537-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D is a steroid hormone with pleiotropic effects. The association between serum 25-hydroxyvitamin D level [25(OH) D] and lupus nephritis are not clearly known. We aim to determine serum 25(OH) D levels in patients with inactive SLE, active SLE without lupus nephritis (LN) and active SLE with LN and to identify clinical predictor of vitamin D deficiency. One hundred and eight SLE patients were included. Patients were classified as Group (Gr) 1, 2 and 3 if they had SLE disease activity index (SLEDAI) < 3, a parts per thousand yen3 but no LN and a parts per thousand yen3 with LN. Important baseline characteristics were collected. 25(OH) D was measured by high performance liquid chromatography (HPLC). SLEDAI in Gr1, Gr2 and Gr3 was 0.7 (0.9), 5.6 (2.3) and 9.2 (5.2), respectively. 43.5 % had vitamin D insufficiency and 29.6 % had vitamin D deficiency. Mean 25(OH) D in each groups was 28.3 (8.0), 26.7 (9.5) and 19.9 (7.6) ng/ml (p < 0.001 comparing Gr1 and 3) (p = 0.003 comparing Gr2 and 3). Vitamin D deficiency was found in 11.1, 22.2 and 55.6 % of Gr1, 2 and 3. Linear regression analysis found that 25(OH) D was significantly correlated with serum albumin (r = 0.28, p = 0.004), inversely correlated with SLEDAI (r = -0.22, p = 0.03) and urinary protein creatinine index (UPCI) (r = -0.28, p = 0.005), but not with sun exposure score, body mass index and estimated GFR. Only UPCI was significantly inversely correlated with 25(OH) D (p = 0.02) from multiple linear regression. LN was a significant predictor of vitamin D deficiency from multivariate logistic regression (OR 5.97; p = 0.006). Vitamin D deficiency and insufficiency was found in 93 and 86 % of LN with proteinuria a parts per thousand yen and < 500 mg/day. We conclude that SLE patients with LN have significantly lower vitamin D level than inactive SLE and active SLE without LN. Hence, nephritis is a significant predictor of vitamin D deficiency in SLE patients.
引用
收藏
页码:1461 / 1467
页数:7
相关论文
共 28 条
[1]   Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate [J].
Agarwal, Rajiv ;
Hynson, Jennifer E. ;
Hecht, Tyler J. W. ;
Light, Robert P. ;
Sinha, Arjun D. .
KIDNEY INTERNATIONAL, 2011, 80 (10) :1073-1079
[2]   Vitamin D: modulator of the immune system [J].
Baeke, Femke ;
Takiishi, Tatiana ;
Korf, Hannelie ;
Gysemans, Conny ;
Mathieu, Chantal .
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) :482-496
[3]   Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters [J].
Bogaczewicz, J. ;
Sysa-Jedrzejowska, A. ;
Arkuszewska, C. ;
Zabek, J. ;
Kontny, E. ;
McCauliffe, D. P. ;
Wozniacka, A. .
LUPUS, 2012, 21 (05) :477-484
[4]   Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus [J].
Bonakdar, Z. S. ;
Jahanshahifar, L. ;
Jahanshahifar, F. ;
Gholamrezaei, A. .
LUPUS, 2011, 20 (11) :1155-1160
[5]   Vitamin D deficiency in patients with active systemic lupus erythematosus [J].
Borba, V. Z. C. ;
Vieira, J. G. H. ;
Kasamatsu, T. ;
Radominski, S. C. ;
Sato, E. I. ;
Lazaretti-Castro, M. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (03) :427-433
[6]   Anti-vitamin D, vitamin D in SLE - Preliminary results [J].
Carvalho, Jozelio Freire ;
Blank, Miri ;
Kiss, Emese ;
Tarr, Tunde ;
Amital, Howard ;
Shoenfeld, Yehuda .
AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS, 2007, 1109 :550-557
[7]   Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation [J].
Chen, Sheng ;
Sims, Gary P. ;
Chen, Xiao Xiang ;
Gu, Yue Ying ;
Chen, Shunle ;
Lipsky, Peter E. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (03) :1634-1647
[8]   25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) [J].
de Boer, Ian H. ;
Ioannou, George N. ;
Kestenbaum, Bryan ;
Brunzell, John D. ;
Weiss, Noel S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (01) :69-77
[9]   Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial [J].
de Zeeuw, Dick ;
Agarwal, Rajiv ;
Amdahl, Michael ;
Audhya, Paul ;
Coyne, Daniel ;
Garimella, Tushar ;
Parving, Hans-Henrik ;
Pritchett, Yili ;
Remuzzi, Giuseppe ;
Ritz, Eberhard ;
Andress, Dennis .
LANCET, 2010, 376 (9752) :1543-1551
[10]   Suppression of renin-angiotensin gene expression in the kidney by paricalcitol [J].
Freundlich, Michael ;
Quiroz, Yasmir ;
Zhang, Zhongyi ;
Zhang, Yan ;
Bravo, Yanauri ;
Weisinger, Jose R. ;
Li, Yan Chun ;
Rodriguez-Iturbe, Bernardo .
KIDNEY INTERNATIONAL, 2008, 74 (11) :1394-1402